As of Friday, December 21, 2012
© Copyright 2013
Albany Herald
After his second failed drug test Friday, resulting in a 50-game ban, Billy Bullock won't be pitching for the Braves any time soon.
NEW YORK — A minor league pitcher in the Atlanta Braves’ organization was suspended Friday for 50 games following a second violation of a drug of abuse.
Triple-A reliever Billy Bullock was penalized by the commissioner’s office.
The 24-year-old right-hander is 11-11 with 50 saves and a 4.33 ERA in four minor league seasons. Bullock split the last two years between Triple-A and Double-A and has averaged more than a strikeout per inning during his career.
There have been 105 suspensions this year under the minor league drug program and eight under the major league program.
SEC baseball tournament expands
HOOVER Ala. — The Southeastern Conference has added two teams and a fifth day to its baseball tournament.
Commissioner Mike Slive announced Friday that the field will expand to 12 teams in the 14-team league starting in 2013 in Hoover, Ala.
The top four seeds will earn a bye in the double-elimination tournament, which starts on May 21. The rest will play that Tuesday with the winners advancing.
The two division champions and other top four seeds have a chance to earn another bye in the tournament, which returns to single elimination on Saturday.
The total number of games played remains at 17, capped by Sunday’s championship.
The SEC has won national titles in three of the last four seasons and had teams advance to the National Championship Series five straight years.
More like this story
- Bulldogs begin SEC tourney play today vs. Vandy ( May 22, 2012 )
- Whole new era: Rockies minor-leaguer Jacobs becomes first North American athlete to be banned for positive HGH test ( August 19, 2011 )
- Mississippi flag could hurt bid for SEC baseball tourney ( August 10, 2010 )
- Albany in talks for minor-league franchise ... again ( April 13, 2010 )
- Quails minor-league baseball team will play in Albany this summer ( May 14, 2010 )


Comments
Use the comment form below to begin a discussion about this content.
Sign in to comment
Or login with:
OpenID